Dealcoholized Red Wine Decreases Systolic and Diastolic Blood Pressure and Increases Plasma Nitric Oxide

Department of Internal Medicine, Hospital Clinic, Villarroel 170, 08036, Barcelona, Spain. .
Circulation Research (Impact Factor: 11.02). 09/2012; 111(8):1065-8. DOI: 10.1161/CIRCRESAHA.112.275636
Source: PubMed


Experimental studies have shown a potential blood pressure (BP) lowering effect of red wine polyphenols, whereas the effects of ethanol and polyphenols on BP in humans are not yet clear.

The aim of the present work was to evaluate the effects of red wine fractions (alcoholic and nonalcoholic) on BP and plasma nitric oxide (NO) in subjects at high cardiovascular risk.

Methods and results:
Sixty-seven men at high cardiovascular risk were studied. After a 2-week run-in period, subjects were randomized into 3 treatment periods in a crossover clinical trial, with a common background diet plus red wine (30g alcohol/day), the equivalent amount of dealcoholized red wine, or gin (30g alcohol/day), lasting 4 weeks each intervention. At baseline and after each intervention, anthropometrical parameters, BP and plasma NO were measured. Systolic and diastolic BP decreased significantly after the dealcoholized red wine intervention and these changes correlated with increases in plasma NO.

Dealcoholized red wine decreases systolic and diastolic BP. Our results point out through an NO-mediated mechanism. The daily consumption of dealcoholized red wine could be useful for the prevention of low to moderate hypertension. Trial registered at ISRCTN88720134.

Download full-text


Available from: Rosa M Lamuela-Raventós,
55 Reads
  • Source
    • "The health properties attributed to beneficial bacteria for human hosts include protection against gastrointestinal disorders and pathogens, nutrient processing, reduction of serum cholesterol, reinforcement of intestinal epithelial cell-tight junctions and increased mucus secretion and modulation of the intestinal immune response through cytokine stimulus [39] [40] [41]. Likewise, in the last decade, a growing body of in vivo interventional and epidemiological studies has furnished new evidence on the wide range of health promoting activities of dietary polyphenols, already documented by in vitro data, including their antiinflammatory, antioxidant, anticarcinogenic, antiadipogenic, antidiabetic and neuroprotective potentials, suggesting an association between the consumption of polyphenol-rich foods and a reduced risk of several chronic diseases [42] [43] [44] [45] [46] [47] [48]. However, the effect of dietary polyphenols on the modulation of the gut ecology, including the underlying mechanisms and the actual benefits of such bioactive agents, is still poorly understood. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The biological properties of dietary polyphenols are greatly dependent on their bioavailability that, in turn, is largely influenced by their degree of polymerization. The gut microbiota play a key role in modulating the production, bioavailability and, thus, the biological activities of phenolic metabolites, particularly after the intake of food containing high-molecular-weight polyphenols. In addition, evidence is emerging on the activity of dietary polyphenols on the modulation of the colonic microbial population composition or activity. However, although the great range of health-promoting activities of dietary polyphenols has been widely investigated, their effect on the modulation of the gut ecology and the two-way relationship "polyphenols ↔ microbiota" are still poorly understood. Only a few studies have examined the impact of dietary polyphenols on the human gut microbiota, and most were focused on single polyphenol molecules and selected bacterial populations. This review focuses on the reciprocal interactions between the gut microbiota and polyphenols, the mechanisms of action and the consequences of these interactions on human health.
    The Journal of nutritional biochemistry 08/2013; 24(8):1415-1422. DOI:10.1016/j.jnutbio.2013.05.001 · 3.79 Impact Factor
  • Source
    • "AWE-treated WKY), presumably due to an increase in NO bioavailability. Furthermore, in WKY we did not see changes either in BP or in components of AChinduced relaxation, in accordance with no alterations in their NO production and SOD activity (Kondrashov et al. 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: As wine polyphenols were shown to possess many positive effects in mammals, including improvement of vascular function, this study investigated the effect of the Slovak Alibernet red wine extract (AWE) on blood pressure and vascular function in young normotensive Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) rats. Six weeks old, male, WKY and SHR were treated with AWE for three weeks at the dose of 24.2 mg/kg/day. Blood pressure (BP), determined by tail-cuff plethysmography, was significantly elevated in SHR vs. WKY and AWE failed to affect it. Lipid peroxidation was evaluated by determination of thiobarbituric acid-reactive substances. Vascular function was assessed in rings of the femoral artery using Mulvany-Halpern's myograph. Maximal endothelium-dependent acetylcholine (ACh)-induced relaxation was reduced in control SHR vs. WKY rats by approximately 9.3 %, which was associated with a significant decrease of its NO-independent component. AWE failed to affect maximal ACh-induced relaxation, both its NO-dependent and independent components, compared to controls of the same genotype. AWE however reduced lipid peroxidation in the left ventricle of both WKY and SHR and in the liver of SHR. In conclusion, three-week administration of AWE failed to reduce BP and to improve endothelial function in the femoral arteries of both genotypes investigated.
    Physiological research / Academia Scientiarum Bohemoslovaca 07/2013; 62(6). · 1.29 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: There is strong epidemiological evidence that light-to-moderate consumption of alcoholic drinks, but neither zero nor more than moderate intake, reduces mortality from all causes and also diminishes cardiovascular risk.(1) The lowest risk for coronary heart disease mortality is seen with 1-2 drinks (12.5-25 g alcohol) per day.Hypertension is a major risk factor for cardiovascular disease, and there is a clear inverse relationship between light-to-moderate alcohol intake and blood pressure. Thus, the reduced cardiovascular risk associated with moderate consumption of alcoholic drinks may be due, in part, to a reduction in blood pressure. The greatest blood pressure benefit seems to be obtained with one drink per day for women and with two drinks per day for men.(2)In most published studies, red wine has been used as the alcoholic test beverage. Red wine produces concentration-dependent vasodilator effects in subcutaneous small resistance arteries obtained from patients with essential hypertension.(3) In addition, red wine and dealcoholized red wine increase flow-mediated vasodilatation (FMD) of the brachial artery in healthy subjects.(4,5) Intake of red wine also counteracts endothelial dysfunction produced by high fat diet in human volunteers 6, and red wine increases FMD and decreases blood pressure in adult cigarette smokers.(7,8) [Extract].
    Circulation Research 09/2012; 111(8):959-61. DOI:10.1161/CIRCRESAHA.112.278705 · 11.02 Impact Factor
Show more